Concordance Index-Based Comparison of Inflammatory and Classical Prognostic Markers in Untreated Hepatocellular Carcinoma
Journal of Clinical Medicine · 05.08.2025 · 14 (15) · 5514
DOI: 10.3390/jcm14155514 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Medicine, online erschienen am 05.08.2025. Verfasst von Natalia Afonso-Luis und 5 weiteren Autor:innen. Beteiligte Einrichtung: Hepato-Bilio-Pancreatic Surgery Unit, Department of General and Digestive Surgery, Hospital Universitario de Gran Canaria Dr. Negrín, Bco. La Ballena…. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 72 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objectives: Inflammation-based markers have emerged as potential prognostic tools in hepatocellular carcinoma (HCC), but comparative data with classical prognostic factors in untreated HCC are limited. This study aimed to evaluate and compare the prognostic performance of inflammatory and conventional markers using Harrell’s concordance index (C-index).
Methods
This retrospective study included 250 patients with untreated HCC. Prognostic variables included age, BCLC stage, Child–Pugh classification, Milan criteria, MELD score, AFP, albumin, Charlson comorbidity index, and the inflammation-based markers neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), monocyte-to-lymphocyte ratio (MLR), Systemic Inflammation Response Index (SIRI), and Systemic Immune-inflammation Index (SIII). Survival was analyzed using Cox regression. Predictive performance was assessed using the C-index, Akaike Information Criterion (AIC), and likelihood ratio tests.
Results
Among the classical markers, BCLC showed the highest predictive performance (C-index: 0.717), while NLR ranked highest among the inflammatory markers (C-index: 0.640), above the MELD score and Milan criteria. In multivariate analysis, NLR ≥ 2.3 remained an independent predictor of overall survival (HR: 1.787; 95% CI: 1.264–2.527; p < 0.001), along with BCLC stage, albumin, Charlson index, and Milan criteria. Including NLR in the model modestly improved the C-index (from 0.781 to 0.794) but significantly improved model fit (Δ–2LL = 10.75; p = 0.001; lower AIC).
Conclusions
NLR is an accessible, cost-effective, and independent prognostic marker for overall survival in untreated HCC. It shows discriminative power comparable to or greater than most conventional predictors and may complement classical stratification tools for HCC.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Hepato-Bilio-Pancreatic Surgery Unit, Department of General and Digestive Surgery, Hospital Universitario de Gran Canaria Dr. Negrín, Bco. La Ballena s/n, 35012 Las Palmas de Gran Canaria, Spain.
- Facultad de Ciencias de la Salud, Universidad de Las Palmas de Gran Canaria, 35001 Las Palmas de Gran Canaria, Spain.
- Department of Radiology, Hospital Universitario de Gran Canaria Dr. Negrín, Bco. La Ballena s/n, 35012 Las Palmas de Gran Canaria, Spain.
ORCID-Profile: Joaquín Marchena-Gómez, Pau Plá-Sánchez, Carmen Rosa Hernández-Socorro
Zitieren
APA
Afonso-Luis, N., Monescillo-Martín, I., Marchena-Gómez, J., Plá-Sánchez, P., Cruz-Benavides, F., & Hernández-Socorro, C. R. (2025). Concordance Index-Based Comparison of Inflammatory and Classical Prognostic Markers in Untreated Hepatocellular Carcinoma. Journal of Clinical Medicine, 14(15), 5514. https://doi.org/10.3390/jcm14155514
Vancouver
Afonso-Luis N, Monescillo-Martín I, Marchena-Gómez J, Plá-Sánchez P, Cruz-Benavides F, Hernández-Socorro CR. Concordance Index-Based Comparison of Inflammatory and Classical Prognostic Markers in Untreated Hepatocellular Carcinoma. Journal of Clinical Medicine. 2025;14(15):5514. doi:10.3390/jcm14155514
BibTeX
@article{AfonsoLuis2025,
author = {Afonso-Luis, Natalia and Monescillo-Martín, Irene and Marchena-Gómez, Joaquín and Plá-Sánchez, Pau and Cruz-Benavides, Francisco and Hernández-Socorro, Carmen Rosa},
title = {Concordance Index-Based Comparison of Inflammatory and Classical Prognostic Markers in Untreated Hepatocellular Carcinoma},
journal = {Journal of Clinical Medicine},
year = {2025},
volume = {14},
number = {15},
pages = {5514},
doi = {10.3390/jcm14155514}
}
EUVIMED